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http:WHAT THIS PAPER ADDS?
Operative and short-term post-operative outcomes show that performing clampless distal anastomosis in
peripheral vascular bypass with reverse thermosensitive gel is effective, technically worthwhile and safe.Objectives: Long occlusions in calciﬁed crural arteries are a major cause of endovascular technical failure in
patients with critical limb ischaemia. Therefore, distal bypasses are mainly performed in patients with heavily
calciﬁed arteries and with consequently delicate clamping. A new reverse thermosensitive polymer (RTP) is an
alternative option to occlude target vessels. The aim of the study is to report our technical experience with RTP
and to assess its safety and efﬁciency to temporarily occlude small calciﬁed arteries during anastomosis time.
Methods: Between July 2010 and December 2011, we used RTP to occlude crural arteries in 20 consecutive
patients with 20 venous distal bypasses. We recorded several operative parameters, such as volume of injected
RTP, duration of occlusion and anastomotic time. Quality of occlusion was subjectively evaluated. Routine on-
table angiography was performed to search for plug emboli. Primary patency, limb salvage and survival rates
were reported at 6 months.
Results: In all patients, crural artery occlusion was achieved with the RTP without the use of an adjunct
occlusion device. Mean volume of RTP used was 0.3 ml proximally and 0.25 ml distally. Mean duration of
occlusion was 14.4  4.5 min, while completion of the distal anastomosis lasted 13.4  4.3 min. Quality of
occlusion was judged as excellent in eight cases and good in 12 cases. Residual plugs were observed in two
patients and removed with an embolectomy catheter, before we amended the technique for dissolution of
RTP. At 6 months, primary patency rate was 75% but limb salvage rate was 87.5%. The 30-day mortality rate
was 10%.
Conclusions: This study shows that RTP is safe when properly dissolved and effective to occlude small calciﬁed
arteries for completion of distal anastomosis.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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usually associated with diabetes, smoking, hypertension or
chronic kidney disease (CKD). PAD is often asymptomatic
and detected by a decrease of the ankle brachial index
(ABI). However, 10e35% of patients with PAD present with
intermittent claudication. Only 1e5% of patients have
a severe PAD manifested by critical limb ischaemia (CLI).1 In
these patients, revascularisation procedure leads to
reduced amputation risk. Different series have shown
5-year limb salvage rates varying between 48% and 63%
with 5-year primary patency rates between 41% and 58%
after distal bypass for CLI.2e4responding author.
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//dx.doi.org/10.1016/j.ejvs.2012.10.005Nowadays, the endovascular approach for CLI is the ﬁrst
line in many vascular centres. The strategy depends on many
factors such as autogenous vein conduit availability, type and
length of arterial occlusions and life expectancy. Long
occlusion in heavily calciﬁed crural arteries is a major cause
of endovascular technical failure and selection for distal
bypass. Indeed, due to improvement in endovascular surgery
and its increasingly extensive area of application, distal
bypass is now exclusively required in very complex cases,
which are precisely long occlusions in extremely calciﬁed
small arteries, as well as multi-operated patients with
endovascular failure. Nevertheless, calciﬁcation at the site of
anastomosis represents also a risk of technical failure during
bypass surgery, mainly due to the presence of calciﬁed pla-
que that prevents an adequate clamping.5 Suturing is yet
difﬁcult in small calciﬁed crural arteries and the anastomosis
completion requires a bloodless ﬁeld, which is achieved
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But all of these standard devices have drawbacks.6e11 In fact,
they cause endothelial lesions with plaque disruption,
leading to potential mid-term development of intimal
hyperplasia.12,13 External occlusion devices may occlude
poorly the heavily calciﬁed arteries when they are simulta-
neously handled with care to spare vessel-wall integrity.
Finally, they require extended dissection of the artery, which
is time consuming and leads also to bleeding from the peri-
arterial venous network. The occlusion catheters usually
achieve an excellent occlusion but have the major disad-
vantage of obstructing the operative ﬁeld.
Therefore, the use of a reverse thermosensitive polymer
(RTP) (LeGoo, Pluromed, Woburn, MA, USA), which is
viscous at room temperature but turns to gel at 37 C, could
be an alternative to the devices in small distal heavily
calciﬁed arteries.14 Indeed, the intravascular administration
of RTP results in an occlusive plug that conforms to the
contour of the lumen, allowing the surgeon to work in
a bloodless ﬁeld.
RTP is an aqueous solution comprised of 20% fraction-
ated poloxamer 407 in saline that has the physical property
to transition from liquid to gel-form at body temperature.
Once in the vessel, it degrades spontaneously by physical
‘erosion’ that makes this water-soluble polymer reversing
back to micelles and then to unimers, with no possibility for
it to turn back into a gel at physiological temperatures.
Poloxamer 407 is a nontoxic, nonabsorbed and non-
metabolised polymer that is excreted through the kidney.14
RTP is supplied in pre-ﬁlled syringes as a sterile single-use
product and is available in multiple volumes to accommo-
date the vessel size and desired plug length (Fig. 1). The
polymer is delivered proximally and distally to theFigure 1. RTP gel LeGoo. Syringe and cannulas with diverse outer
diameters.anastomosis and in potential collateral branches. The plug
either dissolves spontaneously after several minutes or can
be dissolved instantly by cooling, via application of cold
saline into the vessel. As already mentioned, RTP cannot
create a new plug once dissolved. If the plug dissolves
spontaneously before completion of the anastomosis,
additional injections can extend the occlusion time.
Previous studies have demonstrated in cardiovascular
surgery in animals that RTP preserves endothelium and
vascular reactivity, without embolisation into a distal
vascular bed.15,16
The purpose of this study was to evaluate the efﬁcacy
and safety of RTP for the temporary occlusion of crural
vessels during distal bypass surgery in patients with CLI.
METHODS
Between December 2010 and July 2011, we included 20
consecutive patients with CLI Rutherford 4e6. The only
signiﬁcant exclusion criteria were chronic kidney disease
stage 4 and incapacity of discernment. A pre-operative CT
angiogram and vein duplex mapping were obtained for all
patients. The endovascular ﬁrst-line therapy is the strategy
of choice in our department. However, long occlusions of
crural arteries associated with occlusion of the tibial trunk
and below-the-knee popliteal artery are usually treated by
femoro-distal bypasses.
Three vascular surgeons performed the interventions; all
were already familiar with RTP vessel-occlusion technique.
We used RTP only in crural arteries before performing the
distal anastomosis.
We recorded any other device used to occlude the artery
due to failure of RTP. After completion of the distal anas-
tomosis, we performed routine on-table angiography to
assess possible embolisation of RTP in the distal artery,
which was compared to pre-operative images.
This study was approved by the Ethical Committee of the
University Hospital of Lausanne. All informed consents were
obtained before inclusion of the patients.Surgical procedures
All revascularisation procedures were performed under
general or loco-regional anaesthesia. Heparin (50 UI kg1 of
body weight) was administered before clamping arteries.
The occluded target crural artery was minimally dissected to
perform the distal anastomosis. The diameter of the target
artery was estimated and the appropriate syringe and
cannula to inject RTP were selected according to the
manufacturer recommendations. After the arteriotomy, we
inserted the cannula distally and injected a volume of RTP in
order to occlude the vessel totally (Fig. 2). During the
injection, the cannula was withdrawn slowly from the
lumen. This was also done proximal to the anastomosis.
Bleeding from side branches was controlled by direct
injection of RTP into the oriﬁce of the offending branch.
After the total occlusion of the lumen with RTP, the vein
was sutured to the artery with a continuous 7e0 poly-
propylene. If the RTP plug dissolved before completion of
Table 1. Patient characteristics.
Variable Mean (range),
No. (percentage)
N ¼ 20
Demographic data
Age 81 (45e94)
Sex ratio (M/F) 15/5
Comorbidities
Hypertension 16 (80%)
Diabetes 5 (25%)
Tobacco 6 (30%)
Obesity (BMI > 30 kg/m2) 1 (5%)
CKD stage 5 3 (15%)
Rutherford stages
4 8 (40%)
5 7 (35%)
6 5 (25%)
CKD, chronic kidney disease.
Figure 2. Vascular occlusion with plug formation after RTP gel
injection.
Table 2. Operative data.
Variable Mean  SD (range)
or No. (percentage)
N ¼ 20
Proximal anastomosis
SFA 15 (75%)
ATK popliteal artery 5 (25%)
Distal anatomosis
Anterior tibial artery 5 (25%)
Tibioperonal trunk 3 (15%)
Peroneal artery 6 (30%)
Posterior tibial artery 5 (25%)
Pedal artery 1 (5%)
Anastomosis length (mm) 20.2  8.9 (9e50)
Number of RTP injections
Proximally
1 18 (90%)
2 1 (5%)
3 1 (5%)
Distally
1 19 (95%)
2 1 (5%)
Volume of RTP injected (ml)/patient
Proximally 0.3 (0.1e1.3)
Distally 0.25 (0.1e0.6)
Duration (min)
Occlusion 14.4  4.5 (5e22)
Distal anastomosis 13.4  4.3 (7e27)
Bypass procedure 175  49 (94e275)
Quality of bloodless ﬁeld
Excellent 8 (40%)
Good 12 (60%)
RTP residual plug on
control angiography
2 (10%)
SFA, superﬁcial femoral artery; ATK, above the knee.
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was injected to restore the plug. At the end of the suture,
the RTP plug was dissolved with an intraluminal injection of
sterile cold saline solution. The backﬂow bleeding was
assessed before snugging the continuous suture to be sure
that the plug was dissolved. On-table arteriography was
performed using a micropuncture set (Cook Medical, Bloo-
mington, IN, USA) with an injection of 5e10 ml of iodinated
contrast (Visipaque 270, GE Healthcare, Pittsburg, PA, USA)
through the vein conduit. The proximal anastomosis was
then achieved with the use of a traditional occlusion device.
We recorded the volume of RTP injected proximally and
distally in the target vessel, number of required injections as
well as duration of occlusion. Furthermore, duration of the
surgery and anastomotic time were also noticed. Quality of
lumen occlusion by RTP was classiﬁed such as:
excellent ¼ no bleeding; good ¼ minimal bleeding, anas-
tomosis performed without substantial use of accessory
occlusion device; fair ¼ moderate bleeding, anastomosis
performed with substantial use of another occlusion device;
poor ¼ profuse bleeding, anastomosis performed with
continuous use of another occlusion device.
Post-operative follow-up
All patients were followed up with a duplex scan at 1 week,
1 month, 3 months and 6 months post-operatively to
evaluate the patency of the bypass. Duration of hospital-
isation for each patient was recorded.
Statistics
Descriptive data are expressed as mean, standard deviation
and range values. Percentages are given when appropriate.
Deaths were censored with no follow-up.
RESULTS
We performed 20 distal bypasses in 20 consecutive
patients. There were ﬁve female and 15 male patients, with
an average age of 81 years (range 45e94 years). Five
patients (25%) were diabetic and three (15%) had CKD stage
5. Patient characteristics are listed in Table 1.
Proximal anastomoses were performed at the femoral or
at the above-the-knee popliteal arteries and distalanastomoses were all performed at the crural arteries (see
Table 2). Venous conduits were used for all bypasses. RTP
was used in all patients to occlude the crural artery without
the need of any other occlusion device. Mean volume of
RTP used was 0.3 ml (range 0.1e1.3 ml) for the proximal
occlusion of the target vessel and 0.25 ml for the distal
V. Decrouy-Duruz et al. 49occlusion (range 0.1e0.6 ml). Occlusion on the proximal
side was achieved in a single injection of RTP in 18 patients
(90%). Two patients required a second proximal injection
and a third injection was necessary in one of them. Distal
vascular occlusion was obtained in a single injection in 19
patients (95%); one patient required a second distal injec-
tion. Mean duration of occlusion was 14.4  4.5 min (range
5e22 min). Mean duration of distal anastomosis comple-
tion was 13.4  4.3 min (range 7e27 min). Mean anasto-
mosis length was 20.2  8.9 mm (range 9e50 mm). Quality
of occlusion was qualiﬁed as excellent in eight cases (40%)
and good in 12 cases (60%), meaning that no adjunct
occlusion device was needed to complete the anastomosis.
Mean duration of surgical procedure was 175  49 min
(range 94e275 min). Operative data are listed in Table 2.
Routine on-table angiography showed one occluded
collateral of the pedal artery in the ﬁrst patient and an
occlusion of the origin of the peroneal artery in the second
patient. These occlusions were believed to be the result of
residual RTP that had not yet been dissolved. Consequently,
we performed in both cases an embolectomy with a 3
French embolectomy catheter (Lemaitre Vascular, Burling-
ton, MA, USA) and ﬂow was restored.Post-operative outcomes
Mean length of stay was 25.6  13 days (range 11e58
days). Post-operative complications were observed in 10
patients (50%). Seven patients (35%) showed a wound
dehiscence, from which only one needed a surgical revision
(minor complication). Four patients (20%) suffered from
pneumonia and one patient (5%) from myocardial infarct
(major complications). The 30-day mortality rate was 10%
and one patient died later in the hospital. The cause of
death was unrelated to the RTP device but due to pulmo-
nary sepsis in all patients. The 6-month mortality rate was
15%. Mean duration of follow-up was 173  61 days (range
5e250 days). Primary patency rate was 80% at 3 months
and 75% at 6 months. Limb salvage rate was 94% at 3
months and 87.5% at 6 months: two patients had a major
amputation due to unhealing of major necrotic tissue at the
foot level with occluded bypass.
DISCUSSION
Our results suggest that injection of RTP in crural arteries
for blood-ﬂow occlusion offers a good bloodless ﬁeld for
anastomotic procedures with no related major adverse
events.
RTP has already been described to be safe and effective
in achieving a bloodless ﬁeld in peripheral arterial bypass or
arteriovenous ﬁstula for haemodialysis.17,18 We found that
RTP achieved an excellent or good bloodless ﬁeld in 100% of
the cases, which is correlated with previous publications.17e
19 Duration of occlusion is probably limited to 20 min but
can be extended when additional injections are used. This is
usually enough to perform the anastomosis as occlusions
were achieved with a single injection proximally and distally
in 92.5% of patients. The occlusion quality of RTP isdependent on some criteria such as quality of the target
vessel wall and blood pressure. Indeed, smooth endothelial
surface prevents the adherence of RTP to the wall while the
presence of calciﬁcation or atherosclerotic plaque favours it.
In addition, speed of injection and cannula withdrawing are
probably also important to get a homogeneous plug
without air bubbles inside. High blood pressure in large
vessels as in common femoral arteries could also compro-
mise an extended occlusion time. The increase of RTP
viscosity could help to avoid these disadvantages and
extend the indication such as kidney transplantation.
A noteworthy advantage of the RTP is represented by the
limited dissection of the target distal vessel, which is
important to decrease the devitalisation of the surrounding
soft tissue with potential deep venous network bleeding
and damage to collateral arteries. The selected anastomotic
area is the only section of the artery that needs to be
dissected because no clamps need to be placed at
a distance on each side of the arteriotomy. Moreover, the
continuous suture is facilitated by the RTP plug, which
maintains a cylindrical conﬁguration of the target vessel and
can be penetrated by surgical needles.
The dissolution of the plug with cold saline is a critical
step of the procedure. Bouchot and colleagues reported the
need of a Parsonnet probe to dissolve the plug in 11% (10/
91) of coronary bypasses.19 The residual plug was also
described in an anterior tibial artery after an indirect
injection of cold saline.18 We observed two residual occlu-
sions in our ﬁrst two patients, which were removed with an
embolectomy catheter. RTP spontaneous dissolution is
a pure physical process due to ‘surface erosion’ of the
polymer, which we can speed up with application of cold
saline. We think that the residual plugs were seen before
they had completely dissolved because we performed the
control angiography right after completion of distal anas-
tomosis and that we, in someway, failed the instant disso-
lution due to inadequate application of cold saline. We
analysed these two events and concluded that instant
dissolution of RTP requires perforation with the cold saline
cannula of the whole plug (Fig. 3). Since we changed this
step, no additional adverse events were observed. We also
continued to use RTP for femoro-distal bypass surgery after
July 2011. As we did not observe any residual plug in the 10
further control angiographies, we do not now perform this
examination any more but only rely on backﬂow bleeding.
In our experience, we would not recommend completion of
routine on-table angiography when using RTP.
RTP is an alternative device to clamp the vessels with the
advantage of avoiding endothelium damage. Preservation
of endothelium by RTP could be an important issue with
reduction of subsequent intimal hyperplasia. This assump-
tion needs however to be proved and our study was not
designed to detect a reduction of a stenosis at the post-
anastomotic site.
The limitation of our study is precisely the small number
of patients with a short-term follow-up (6 months). Yet the
aim of our investigation was to evaluate the technical
success rate of the RTP device, before performing a larger
Figure 3. Dissolution of the RTP plug with cold saline. A, the
cannula must perforate the whole plug before cold saline is
injected. B, the cannula has to be progressively withdrawn as the
cold saline is injected and the plug dissolved.
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back of the device is its cost that represents one and a half
times the price of two occlusion catheters.
In conclusion, this study shows that the novel RTP is safe
and effective in occluding calciﬁed crural arteries, and
allows sufﬁcient time for performing challenging distal
anastomoses in patients with CLI. RTP could be less dele-
terious for endothelium and could therefore contribute to
improve patency rate of distal bypass in patients with
heavily calciﬁed crural arteries.
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